Financhill
Sell
43

HD Quote, Financials, Valuation and Earnings

Last price:
$388.47
Seasonality move :
7.29%
Day range:
$383.05 - $393.29
52-week range:
$323.77 - $439.37
Dividend yield:
2.29%
P/E ratio:
26.67x
P/S ratio:
2.52x
P/B ratio:
67.40x
Volume:
7.6M
Avg. volume:
3.6M
1-year change:
12.6%
Market cap:
$390B
Revenue:
$152.7B
EPS (TTM):
$14.72
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Revenue $110.2B $132.1B $151.2B $157.4B $152.7B
Revenue Growth (YoY) 1.87% 19.86% 14.42% 4.13% -3.01%
 
Cost of Revenues $72.7B $87.3B $100.3B $104.6B $101.7B
Gross Profit $37.6B $44.9B $50.8B $52.8B $51B
Gross Profit Margin 34.09% 33.95% 33.63% 33.53% 33.38%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $19.7B $24.4B $25.4B $26.3B $26.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $21.7B $26.6B $27.8B $28.7B $29.3B
Operating Income $15.8B $18.3B $23B $24B $21.7B
 
Net Interest Expenses $1.1B $1.3B $1.3B $1.6B $1.8B
EBT. Incl. Unusual Items $14.7B $17B $21.7B $22.5B $19.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.5B $4.1B $5.3B $5.4B $4.8B
Net Income to Company $11.2B $12.9B $16.4B $17.1B $15.1B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $11.2B $12.9B $16.4B $17.1B $15.1B
 
Basic EPS (Cont. Ops) $10.29 $11.98 $15.59 $16.74 $15.16
Diluted EPS (Cont. Ops) $10.25 $11.94 $15.53 $16.69 $15.11
Weighted Average Basic Share $1.1B $1.1B $1.1B $1B $999M
Weighted Average Diluted Share $1.1B $1.1B $1.1B $1B $1B
 
EBITDA $18.2B $20.8B $25.9B $27.1B $25.1B
EBIT $15.9B $18.3B $23.1B $24.1B $21.9B
 
Revenue (Reported) $110.2B $132.1B $151.2B $157.4B $152.7B
Operating Income (Reported) $15.8B $18.3B $23B $24B $21.7B
Operating Income (Adjusted) $15.9B $18.3B $23.1B $24.1B $21.9B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $33.5B $36.8B $38.9B $37.7B $40.2B
Revenue Growth (YoY) 23.19% 9.79% 5.57% -2.99% 6.65%
 
Cost of Revenues $22.1B $24.3B $25.6B $25B $26.8B
Gross Profit $11.5B $12.6B $13.2B $12.7B $13.4B
Gross Profit Margin 34.16% 34.12% 34.02% 33.78% 33.38%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6.1B $6.2B $6.5B $6.6B $7.2B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $6.6B $6.8B $7.1B $7.3B $8B
Operating Income $4.9B $5.8B $6.1B $5.4B $5.4B
 
Net Interest Expenses $329M $326M $406M $438M $595M
EBT. Incl. Unusual Items $4.5B $5.5B $5.7B $5B $4.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1B $1.3B $1.4B $1.2B $1.2B
Net Income to Company $3.4B $4.1B $4.3B $3.8B $3.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.4B $4.1B $4.3B $3.8B $3.6B
 
Basic EPS (Cont. Ops) $3.20 $3.94 $4.25 $3.83 $3.68
Diluted EPS (Cont. Ops) $3.18 $3.92 $4.24 $3.81 $3.67
Weighted Average Basic Share $1.1B $1B $1B $996M $991M
Weighted Average Diluted Share $1.1B $1.1B $1B $999M $993M
 
EBITDA $5.5B $6.5B $6.9B $6.3B $6.4B
EBIT $4.9B $5.8B $6.2B $5.5B $5.4B
 
Revenue (Reported) $33.5B $36.8B $38.9B $37.7B $40.2B
Operating Income (Reported) $4.9B $5.8B $6.1B $5.4B $5.4B
Operating Income (Adjusted) $4.9B $5.8B $6.2B $5.5B $5.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $125.6B $147.7B $157.3B $153.7B $154.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $82.9B $97.9B $104.6B $102.3B $102.8B
Gross Profit $42.8B $49.8B $52.7B $51.4B $51.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.1B $25.2B $26.2B $26.5B $27.7B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $25.2B $27.5B $28.6B $29.1B $30.6B
Operating Income $17.6B $22.3B $24.1B $22.3B $21.2B
 
Net Interest Expenses $1.3B $1.3B $1.5B $1.7B $2B
EBT. Incl. Unusual Items $16.3B $21B $22.6B $20.6B $19.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.8B $5.1B $5.5B $4.9B $4.6B
Net Income to Company $12.5B $15.9B $17.1B $15.7B $14.6B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12.5B $15.9B $17.1B $15.7B $14.6B
 
Basic EPS (Cont. Ops) $11.62 $15.01 $16.65 $15.63 $14.76
Diluted EPS (Cont. Ops) $11.56 $14.96 $16.59 $15.58 $14.72
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $20.1B $25.1B $27.1B $25.6B $25B
EBIT $17.7B $22.3B $24.1B $22.5B $21.4B
 
Revenue (Reported) $125.6B $147.7B $157.3B $153.7B $154.6B
Operating Income (Reported) $17.6B $22.3B $24.1B $22.3B $21.2B
Operating Income (Adjusted) $17.7B $22.3B $24.1B $22.5B $21.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $99.8B $115.4B $121.6B $117.9B $119.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $65.8B $76.5B $80.7B $78.4B $79.5B
Gross Profit $34B $39B $40.9B $39.5B $40.3B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.3B $19B $19.7B $19.9B $21B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $19.8B $20.8B $21.6B $21.9B $23.2B
Operating Income $14.2B $18.2B $19.3B $17.5B $17B
 
Net Interest Expenses $973M $980M $1.2B $1.3B $1.5B
EBT. Incl. Unusual Items $13.2B $17.2B $18.1B $16.2B $15.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3.2B $4.2B $4.4B $3.9B $3.7B
Net Income to Company $10B $13.1B $13.7B $12.3B $11.8B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10B $13.1B $13.7B $12.3B $11.8B
 
Basic EPS (Cont. Ops) $9.33 $12.35 $13.42 $12.32 $11.93
Diluted EPS (Cont. Ops) $9.28 $12.31 $13.38 $12.28 $11.90
Weighted Average Basic Share $3.2B $3.2B $3.1B $3B $3B
Weighted Average Diluted Share $3.2B $3.2B $3.1B $3B $3B
 
EBITDA $16.1B $20.4B $21.5B $20.1B $20B
EBIT $14.2B $18.2B $19.3B $17.7B $17.2B
 
Revenue (Reported) $99.8B $115.4B $121.6B $117.9B $119.8B
Operating Income (Reported) $14.2B $18.2B $19.3B $17.5B $17B
Operating Income (Adjusted) $14.2B $18.2B $19.3B $17.7B $17.2B
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Cash and Equivalents $2.1B $7.9B $2.3B $2.8B $3.8B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.7B $2.6B $2.9B $2.8B $2.8B
Inventory $14.5B $16.6B $22.1B $24.9B $21B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1B $963M $1.2B $1.5B $1.7B
Total Current Assets $19.8B $28.5B $29.1B $32.5B $29.8B
 
Property Plant And Equipment $28.4B $30.7B $31.2B $32.6B $34B
Long-Term Investments -- -- -- -- --
Goodwill $2.3B $7.1B $7.4B $7.4B $8.5B
Other Intangibles -- -- -- -- --
Other Long-Term Assets $807M $4.3B $4.2B $4B $4.3B
Total Assets $51.2B $70.6B $71.9B $76.4B $76.5B
 
Accounts Payable $7.8B $11.6B $13.5B $11.4B $10B
Accrued Expenses $4.2B $5.5B $6.3B $5.8B $6.3B
Current Portion Of Long-Term Debt $1.8B $1.4B $2.4B $1.2B $1.4B
Current Portion Of Capital Lease Obligations $828M $828M $830M $945M $1.1B
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $18.4B $23.2B $28.7B $23.1B $22B
 
Long-Term Debt $28.7B $35.8B $36.6B $42B $42.7B
Capital Leases -- -- -- -- --
Total Liabilities $54.4B $67.3B $73.6B $74.9B $75.5B
 
Common Stock $89M $89M $90M $90M $90M
Other Common Equity Adj -$739M -$671M -$704M -$718M -$477M
Common Equity -$3.1B $3.3B -$1.7B $1.6B $1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -$3.1B $3.3B -$1.7B $1.6B $1B
 
Total Liabilities and Equity $51.2B $70.6B $71.9B $76.4B $76.5B
Cash and Short Terms $2.1B $7.9B $2.3B $2.8B $3.8B
Total Debt $31.5B $37.2B $40.1B $43.2B $44.1B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $14.7B $5.1B $2.5B $2.1B $1.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.7B $3.5B $3.7B $3.9B $5.2B
Inventory $16.2B $20.6B $25.7B $22.8B $23.9B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1B $1.3B $1.8B $1.9B $1.7B
Total Current Assets $34.5B $30.5B $33.7B $30.7B $32.9B
 
Property Plant And Equipment $29.3B $30.8B $31.8B $32.8B $35.1B
Long-Term Investments -- -- -- -- --
Goodwill $2.2B $7.4B $7.4B $7.9B $19.4B
Other Intangibles -- -- -- -- $9.1B
Other Long-Term Assets $897M $4.3B $4B $4.2B $681M
Total Assets $66.9B $73B $76.9B $75.6B $97.3B
 
Accounts Payable $12.9B $13.4B $12.4B $11.5B $13.5B
Accrued Expenses $5.6B $5.8B $5.9B $6B $6.5B
Current Portion Of Long-Term Debt $2.5B $2.4B $1.2B $1.4B $3.2B
Current Portion Of Capital Lease Obligations $842M $827M $942M $1B $1.3B
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $25.4B $26.9B $24.3B $23.6B $29.1B
 
Long-Term Debt $32.8B $36.7B $41.7B $40.6B $50.1B
Capital Leases -- -- -- -- --
Total Liabilities $65.4B $72B $75.6B $74.1B $91.5B
 
Common Stock $89M $90M $90M $90M $90M
Other Common Equity Adj -$965M -$602M -$856M -$662M -$939M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.5B $1B $1.3B $1.4B $5.8B
 
Total Liabilities and Equity $66.9B $73B $76.9B $75.6B $97.3B
Cash and Short Terms $14.7B $5.1B $2.5B $2.1B $1.5B
Total Debt $35.3B $39.1B $43B $41.9B $54.6B
Period Ending 2020-01-31 2021-01-31 2022-01-31 2023-01-31 2024-01-31
Net Income to Stockholders $11.2B $12.9B $16.4B $17.1B $15.1B
Depreciation & Amoritzation $2.3B $2.5B $2.9B $3B $3.2B
Stock-Based Compensation $251M $310M $399M $366M $380M
Change in Accounts Receivable -$170M -$465M -$435M $111M $134M
Change in Inventories -$593M -$1.7B -$5.4B -$2.8B $4.1B
Cash From Operations $13.7B $18.8B $16.6B $14.6B $21.2B
 
Capital Expenditures $2.7B $2.5B $2.6B $3.1B $3.2B
Cash Acquisitions -- -$7.8B -$421M -- -$1.5B
Cash From Investing -$2.7B -$10.2B -$3B -$3.1B -$4.7B
 
Dividends Paid (Ex Special Dividend) -$6B -$6.5B -$7B -$7.8B -$8.4B
Special Dividend Paid
Long-Term Debt Issued $3.4B $7.9B $3B $6.9B $2B
Long-Term Debt Repaid -$1.1B -$2.9B -$1.5B -$2.5B -$1.3B
Repurchase of Common Stock -$7B -$791M -$14.8B -$6.7B -$8B
Other Financing Activities -$140M -$154M -$145M -$188M -$156M
Cash From Financing -$10.8B -$3B -$19.1B -$11B -$15.4B
 
Beginning Cash (CF) $1.8B $2.1B $7.9B $2.3B $2.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $236M $5.7B -$5.5B $482M $1B
Ending Cash (CF) $2.1B $7.9B $2.3B $2.8B $3.8B
 
Levered Free Cash Flow $11B $16.4B $14B $11.5B $17.9B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $3.4B $4.1B $4.3B $3.8B $3.6B
Depreciation & Amoritzation $631M $714M $743M $827M $995M
Stock-Based Compensation $79M $86M $90M $85M $106M
Change in Accounts Receivable -$103M -$212M -$17M -$46M -$277M
Change in Inventories -$2.6B -$1.7B $261M $380M -$897M
Cash From Operations $2.6B $3.4B $2.8B $4.2B $4.2B
 
Capital Expenditures $471M $695M $769M $671M $818M
Cash Acquisitions -- -- -- -$580M -$43M
Cash From Investing -$431M -$674M -$784M -$1.2B -$814M
 
Dividends Paid (Ex Special Dividend) -$1.6B -$1.7B -$1.9B -$2.1B -$2.2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $3B $3B -- -$1.2B
Long-Term Debt Repaid -$30M -$46M -$596M -$70M -$100M
Repurchase of Common Stock -- -$3.5B -$1.2B -$1.5B --
Other Financing Activities -$5M -$24M -$22M -$4M -$11M
Cash From Financing -$1.6B -$2.3B -$749M -$3.7B -$3.5B
 
Beginning Cash (CF) $14.1B $4.6B $1.3B $2.8B $1.6B
Foreign Exchange Rate Adjustment -$14M $11M -$103M -$87M -$25M
Additions / Reductions $527M $490M $1.3B -$669M -$57M
Ending Cash (CF) $14.7B $5.1B $2.5B $2.1B $1.5B
 
Levered Free Cash Flow $2.1B $2.7B $2.1B $3.6B $3.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $12.5B $15.9B $17.1B $15.7B $14.6B
Depreciation & Amoritzation $2.4B $2.8B $3B $3.2B $3.6B
Stock-Based Compensation $288M $388M $373M $380M $408M
Change in Accounts Receivable -$452M -$418M -$214M -$115M $4M
Change in Inventories -$523M -$3.8B -$5.3B $3B $895M
Cash From Operations $20.3B $14.8B $13.2B $21B $19.9B
 
Capital Expenditures $2.3B $2.7B $3B $3.3B $3.2B
Cash Acquisitions -- -$8.2B -$5M -$795M -$18.3B
Cash From Investing -$2.2B -$10.9B -$3.1B -$4B -$21.5B
 
Dividends Paid (Ex Special Dividend) -$6.3B -$6.9B -$7.6B -$8.2B -$8.8B
Special Dividend Paid
Long-Term Debt Issued $7B $6B $6.9B -- $13.3B
Long-Term Debt Repaid -$2.2B -$1.5B -$3.5B -$233M -$1.4B
Repurchase of Common Stock -$3.8B -$10.4B -$9.6B -$8B -$2.1B
Other Financing Activities -$152M -$182M -$170M -$149M -$233M
Cash From Financing -$5.6B -$13.7B -$12.6B -$17.4B $1.1B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $12.5B -$9.7B -$2.4B -$379M -$504M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $18B $12.1B $10.2B $17.8B $16.6B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $10B $13.1B $13.7B $12.3B $11.8B
Depreciation & Amoritzation $1.9B $2.1B $2.2B $2.4B $2.8B
Stock-Based Compensation $234M $312M $286M $300M $328M
Change in Accounts Receivable -$580M -$533M -$312M -$538M -$668M
Change in Inventories -$1.7B -$3.9B -$3.7B $2.1B -$1.1B
Cash From Operations $17.4B $13.4B $10B $16.4B $15.1B
 
Capital Expenditures $1.5B $1.7B $2.2B $2.4B $2.4B
Cash Acquisitions -- -$416M -- -$795M -$17.6B
Cash From Investing -$1.5B -$2.1B -$2.2B -$3.1B -$19.9B
 
Dividends Paid (Ex Special Dividend) -$4.8B -$5.3B -$5.9B -$6.3B -$6.7B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5B $3B $6.9B -- $11.3B
Long-Term Debt Repaid -$2.8B -$1.5B -$3.5B -$1.2B -$1.4B
Repurchase of Common Stock -$791M -$10.4B -$5.1B -$6.5B -$649M
Other Financing Activities -$132M -$160M -$185M -$146M -$223M
Cash From Financing -$3.4B -$14.1B -$7.5B -$13.9B $2.6B
 
Beginning Cash (CF) $25B $19.1B $6.4B $6.8B $9.6B
Foreign Exchange Rate Adjustment -$20M $27M -$110M -$67M -$93M
Additions / Reductions $12.5B -$2.9B $229M -$632M -$2.1B
Ending Cash (CF) $37.5B $16.3B $6.6B $6.1B $7.4B
 
Levered Free Cash Flow $15.9B $11.6B $7.8B $14.1B $12.8B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 6.55% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.29% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock